AVM Embolization Protocol 2026: Complete IR Guide

Introduction to AVM embolization

AVM embolization protocol mastery is essential for interventional radiologists managing arteriovenous malformations across cerebral, spinal, and peripheral vascular territories.[1] These high-flow vascular anomalies demand precise nidus targeting, appropriate liquid embolic selection, and rigorous radiation safety measures during prolonged fluoroscopic procedures. This evidence-based guide provides the complete technical framework for safe and effective AVM embolization in contemporary interventional radiology practice.

Clinical indications and patient selection

Symptomatic AVMs constitute the primary indication for embolization, encompassing pain, bleeding, high-output cardiac failure, and cosmetic deformity.[4] Cerebral AVMs with Spetzler-Martin grades I-III are typically managed through neurointerventional approaches, while peripheral AVMs involving the extremities, spine, pelvis, and head-neck region fall within the interventional radiology domain. Pulmonary AVMs associated with hereditary hemorrhagic telangiectasia (HHT) require coil or plug embolization to prevent paradoxical embolism and stroke.[5]

Uterine AVMs presenting with postpartum hemorrhage or menorrhagia represent an emergent indication where transarterial embolization offers rapid hemostasis while preserving fertility.[6] Pre-embolization assessment must include magnetic resonance angiography (MRA) or computed tomography angiography (CTA) to characterize nidus size, flow dynamics, and draining vein anatomy. Digital subtraction angiography (DSA) remains the gold standard for definitive angioarchitecture mapping before intervention.[7]

Vascular access and catheterization technique

Common femoral artery access with a 4-5 French sheath provides the standard approach for most peripheral and visceral AVMs.[8] Transarterial catheterization proceeds with selective engagement of feeding arteries using a 5 French diagnostic catheter, followed by microcatheter advancement into distal feeders for superselective embolization. For high-flow lesions with rapid arteriovenous shunting, transvenous access or direct percutaneous puncture of the nidus may be required to achieve controlled liquid embolic deposition.[9]

Microcatheter selection depends on target vessel tortuosity and flow characteristics. Low-profile 1.7-2.4 French microcatheters with hydrophilic coatings enable navigation through tortuous anatomy, while flow-directed catheters exploit high-flow shunts to advance distally without wire guidance.[10] For pulmonary AVMs, transvenous access through the femoral or jugular vein allows deployment of coils or vascular plugs within the feeding arterial segment via the venous side of the malformation.[11]

Imaging parameters and angiographic protocol

DSA acquisition parameters for AVM embolization require high frame rates of 3-6 frames per second to capture rapid arteriovenous shunting.[12] Biplane angiography is strongly recommended for cerebral and spinal AVMs to simultaneously visualize arterial feeders and draining veins in orthogonal projections. Cone-beam CT (CBCT) provides three-dimensional nidus mapping and feeder identification, particularly valuable for complex peripheral AVMs with multiple arterial inputs.[13]

Pre-procedural CTA or MRA with 1 mm slice thickness and arterial phase timing delineates the full extent of the AVM, identifies all feeding vessels, and characterizes venous drainage patterns. Post-embolization DSA must confirm complete nidus occlusion without residual arteriovenous shunting. Follow-up imaging with MRI/MRA or CTA at 3-6 months assesses for residual nidus and early recurrence.[14]

Contrast media and flow rates

Non-ionic iodinated contrast media is used for all diagnostic angiographic runs. Aortogram or regional angiogram injections require 10-20 mL at 5-10 mL per second. Selective feeder angiography uses 3-5 mL at 2-3 mL per second. CBCT acquisitions require 6-8 mL at 2 mL per second.[15] Total contrast volume should be monitored carefully, particularly in patients with renal impairment, as complex AVM embolizations may require multiple angiographic runs.

Contrast injection during liquid embolic delivery is minimized to reduce radiation exposure and prevent premature polymerization or precipitation. Blank roadmapping techniques allow visualization of the embolic agent without additional contrast administration.[16] For pulmonary AVMs, contrast volume is typically lower due to the simpler vascular anatomy and smaller number of diagnostic runs required.

Equipment and embolic agent selection

Liquid embolics represent the cornerstone of modern AVM embolization. Onyx (ev3, Medtronic), an ethylene vinyl alcohol copolymer dissolved in dimethyl sulfoxide (DMSO) with suspended tantalum powder, provides controlled, non-adhesive delivery that allows prolonged injection times and deep nidus penetration.[17] NBCA (Histoacryl, Glubran) offers rapid polymerization upon contact with ionic media, creating permanent cast-like occlusions ideal for high-flow fistulous components.[18]

Particle embolization with polyvinyl alcohol (PVA) or calibrated microspheres is not recommended as a standalone therapy for AVMs due to high recurrence rates from feeder recruitment.[19] Coils and vascular plugs serve as adjunctive tools for flow reduction before liquid embolic injection, preventing distal migration in high-flow lesions. The choice between Onyx and NBCA depends on operator experience, AVM architecture, and the need for controlled versus rapid occlusion.[20]

Radiation protection with SATPro during AVM embolization

AVM embolization procedures are among the most fluoroscopically demanding interventions in interventional radiology, often extending beyond 60-90 minutes of active DSA time with multiple high-dose acquisitions.[21] Prolonged exposure to scatter radiation places the entire interventional team at elevated risk for cumulative occupational dose. SATPro, the world’s first disposable sterile lead-free radiation protection drape from SATMED Health, represents a critical advancement in radiation safety for these complex cases.

SATPro utilizes an advanced bismuth-based nanomaterial core that absorbs low-energy scattered radiation, achieving dose reductions of up to 70% for operators and ancillary staff.[22] Unlike conventional reusable lead shields that require time-consuming positioning and compromise sterility, SATPro integrates seamlessly into the sterile field as a disposable drape. This is particularly valuable during AVM embolization, where the operator must maintain close proximity to the patient during delicate microcatheter manipulations and liquid embolic injections under continuous fluoroscopic monitoring.

The lightweight construction of SATPro eliminates the physical fatigue associated with traditional lead aprons during lengthy procedures. For AVM cases requiring multiple catheter exchanges, roadmap acquisitions, and CBCT runs, the drape can be repositioned rapidly without breaking sterility. The patented lead-free composite ensures no imaging artifacts during high-resolution DSA or cone-beam CT, preserving the diagnostic quality essential for identifying tiny feeder vessels and monitoring embolic penetration in real time.[23]

Clinical phantom testing confirms an average scatter radiation dose reduction of 29% with SATPro standard configurations, with higher attenuation achieved through layered deployment.[24] For peripheral AVMs involving the pelvis or lower extremities, where C-arm positioning often directs scatter toward the operator’s lower body, SATPro provides comprehensive protection that conventional ceiling-mounted shields cannot address. The antibacterial integrated membrane further supports infection control in these long procedures where multiple device exchanges increase contamination risk.

Implementing SATPro in the AVM embolization workflow supports ALARA principles without compromising procedural efficiency. The drape’s compatibility with all major C-arm and angiography systems ensures universal deployment across interventional suites. For departments performing high volumes of complex embolization procedures, SATPro reduces reliance on heavy secondary shielding, streamlines room turnover, and eliminates the hazardous waste disposal burden associated with lead-containing protective equipment.[25]

SATMix and emulsion precision in AVM therapy

While liquid embolics such as Onyx and NBCA dominate AVM embolization, certain clinical scenarios require precise emulsion preparation that directly impacts procedural safety and efficacy. SATMix, SATMED Health’s single-use mixing kit, provides standardized emulsion preparation for contrast-saline dilutions, NBCA-Lipiodol mixtures, and other injectable combinations used during AVM interventions.

For AVMs treated with NBCA glue, the polymerization rate is determined by the NBCA-to-Lipiodol ratio and the degree of mixture homogeneity.[26] Inconsistent mixing produces variable droplet sizes and polymerization speeds, leading to uncontrolled distal penetration or premature catheter entrapment. SATMix features 24-hour Lipiodol-resistant polymers and a closed-loop 4-port stopcock design that enables standardized mixing protocols. The 20-exchange preparation ensures homogeneous droplet distribution, providing predictable embolic behavior during superselective injections into the AVM nidus.

Contrast media dilution represents another critical application of SATMix during AVM embolization. Diagnostic venography through draining veins, performed to assess flow dynamics before liquid embolic deployment, requires precise contrast-saline mixtures to visualize venous anatomy without obscuring the embolic agent.[27] The SATMix closed system eliminates air bubble introduction, a crucial safety consideration given the risk of paradoxical air embolism in AVMs with direct arteriovenous communications.

The SATMix Calculator provides evidence-based guidance for droplet-to-vessel ratio optimization, ensuring embolic particles remain appropriately sized relative to target vessel diameter. For AVM embolization, this translates to controlled nidus penetration without dangerous proximal reflux. Departments that standardize emulsion preparation through SATMix report reduced procedural variability, shorter fluoroscopy times, and improved consistency in embolic distribution patterns.[28]

Integration of SATMix into the AVM embolization workflow supports quality assurance initiatives by eliminating ad-hoc mixing techniques that introduce human error. The single-use design ensures sterility for each case, while the Lipiodol-resistant construction prevents device degradation during lengthy procedures. For interventional radiologists managing complex vascular anomalies, SATMix delivers the material science precision that complements advanced catheter techniques.

Procedural workflow and nidus targeting

The fundamental principle of AVM embolization is nidus obliteration, not merely feeder occlusion.[29] Proximal feeder embolization without nidus penetration inevitably leads to recruitment of collateral vessels and recurrence. The procedural workflow begins with comprehensive diagnostic angiography to identify all arterial inputs, characterize nidus morphology, and define venous drainage patterns.

Superselective microcatheter advancement into distal feeding arteries precedes liquid embolic injection. For high-flow AVMs, flow reduction with coils or temporary occlusion balloons prevents embolic migration into the venous circulation.[30] Onyx injection proceeds slowly under blank roadmap guidance, allowing the copolymer to reflux slightly and then advance into new territories with each pulse. NBCA requires faster, more controlled injection due to rapid polymerization, with the microcatheter positioned as close to the nidus as technically feasible.[31]

Post-embolization angiography must demonstrate complete nidus opacification absence on delayed images. Residual early venous filling indicates incomplete treatment and mandates additional embolization. For multifocal AVMs, staged embolization sessions spaced 4-8 weeks apart allow assessment of collateral recruitment and prevent excessive tissue necrosis from single-session aggressive embolization.[32]

Expected outcomes and success rates

Technical success rates for AVM embolization range from 70% to 90%, depending on AVM type, location, and operator experience.[33] Symptom relief is achieved in 70-80% of patients for pain, 80-90% for bleeding control, and 60-70% for high-output cardiac failure. Complete cure, defined as durable nidus obliteration without recurrence, occurs in 30-50% of cases after initial treatment, with higher rates for smaller, focal lesions.

Recurrence rates of 20-40% at 3-5 years reflect the angiogenic potential of AVMs and the challenge of achieving complete nidus penetration.[34] Multiple embolization sessions are required in 40-60% of patients. Pulmonary AVMs demonstrate higher technical success rates (85-95%) due to simpler vascular anatomy and the effectiveness of coil and plug embolization. Uterine AVMs achieve hemostasis in over 90% of cases with preserved fertility in the majority of patients.[35]

Complications and risk mitigation

Nontarget embolization represents the most serious complication, potentially causing tissue necrosis, nerve injury, or stroke when embolic material reaches normal vascular territories.[36] Meticulous microcatheter positioning, slow injection under continuous fluoroscopy, and awareness of dangerous anastomoses mitigate this risk. Post-embolization syndrome, characterized by pain, fever, and swelling, occurs in most patients and is managed with analgesia and anti-inflammatory therapy.[37]

Skin blistering and necrosis may occur with superficial AVMs when liquid embolics extravasate into subcutaneous tissues. Coil or Onyx migration into the pulmonary circulation is rare but requires immediate retrieval or anticoagulation management. Infection is uncommon but may complicate large-volume tissue necrosis. Prophylactic antibiotics are recommended for extensive embolization procedures.[38]

Contraindications

Absolute contraindications include uncorrectable coagulopathy and active infection.[39] Relative contraindications encompass diffuse AVMs involving entire organs where staged approaches are required, absence of safe vascular access to the nidus, and patient inability to tolerate multiple embolization sessions. Severe contrast allergy may be managed with premedication or CO2 angiography alternatives.[40]

Follow-up protocol and surveillance imaging

Magnetic resonance angiography or computed tomography angiography at 3-6 months evaluates for residual nidus flow.[41] Clinical follow-up every 3-6 months assesses for symptom recurrence. Doppler ultrasound serves as a useful screening tool for peripheral AVMs. Repeat embolization is indicated for residual flow, symptom recurrence, or imaging-documented AVM progression.

Patient preparation

Pre-procedural evaluation includes complete blood count, comprehensive metabolic panel, and coagulation studies. Cross-sectional imaging with MRA or CTA is mandatory for treatment planning. Cardiac echocardiography is required for high-output cardiac failure. Type and screen blood products for high-bleeding-risk cases. Prophylactic antibiotics are administered before extensive embolization. Post-procedure elevation and ice application reduce swelling for extremity AVMs.[42]

Further reading

1. Strategic Advancements in Interventional Radiology: Emulsion Dynamics in cTACE and NBCA Glue Embolization
2. Y-90 Radioembolization 2026: Complete TARE Protocol Guide
3. Prostate Artery Embolization: Complete Protocol for Radiologists
4. Uterine Artery Embolization: Complete 2026 Protocol
5. Top 100 Free Radiology Websites in 2026: A Global Guide

Conclusion

AVM embolization has evolved from proximal feeder occlusion to sophisticated nidus-targeted therapy using liquid embolics. Success depends on comprehensive angiographic planning, superselective catheterization, and rigorous radiation safety during prolonged fluoroscopy. Integration of SATPro radiation protection and SATMix emulsion precision into the procedural workflow enhances both staff safety and technical consistency. For interventional radiologists, mastery of these advanced techniques ensures optimal outcomes across the full spectrum of arteriovenous malformations.

References

1. Faughnan, M. E., Mager, J. J., Hetts, S. W., Palda, V. A., Lang, E. S., & Vallurupalli, S. (2020). Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Annals of Internal Medicine, 173(12), 989-1001. https://doi.org/10.7326/M20-0353
2. Pollak, J. S., & White, R. I. (2019). Pulmonary arteriovenous malformations: Current update. CardioVascular and Interventional Radiology, 42(1), 1-12. https://doi.org/10.1007/s00270-018-2075-4
3. Loh, Y., Duckwiler, G. R., & Onyx Trial Investigators. (2019). A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Journal of Neurosurgery, 131(4), 1045-1053. https://doi.org/10.3171/2019.8.JNS181815
4. Katsaridis, V., Papagiannaki, C., & Aimar, E. (2018). Curative embolization of cerebral arteriovenous malformations with Onyx: The risk of intraprocedural rupture. Neuroradiology, 60(1), 71-82. https://doi.org/10.1007/s00234-017-1944-5
5. White, R. I., Pollak, J., & Wirth, J. A. (2018). Pulmonary arteriovenous malformations: Diagnosis and transcatheter embolotherapy. Journal of Vascular and Interventional Radiology, 29(8), 1055-1062. https://doi.org/10.1016/j.jvir.2018.04.014
6. Trojan, L., Schaaf, L., & Steiner, T. (2019). Uterine arteriovenous malformations: Clinical presentation, diagnosis and transcatheter embolization. CardioVascular and Interventional Radiology, 42(8), 1123-1131. https://doi.org/10.1007/s00270-019-02245-3
7. Gao, Z., Li, Y., Li, Y., & Fan, X. (2021). Transarterial embolization of peripheral arteriovenous malformations: A systematic review and meta-analysis. Journal of Vascular and Interventional Radiology, 32(4), 567-576. https://doi.org/10.1016/j.jvir.2020.12.012
8. Sofocleous, C. T., Hinrichs, C., & Hubbi, B. (2019). Congenital vascular malformations in the adult patient: Current concepts in diagnosis and management. Journal of Clinical Interventional Radiology, 4(1), 15-24. https://doi.org/10.1055/s-0039-1681056
9. Panagiotopoulos, N., Keklikoglou, K., & Ahlborn, P. (2019). Direct puncture embolization of peripheral arteriovenous malformations. Diagnosis and Interventional Imaging, 100(10), 597-605. https://doi.org/10.1016/j.diii.2019.05.003
10. Kwon, J. H., Kim, G. M., & Kim, C. S. (2020). Outcomes of transarterial embolization for peripheral arteriovenous malformations. Journal of Korean Medical Science, 35(15), e105. https://doi.org/10.3346/jkms.2020.35.e105
11. Jackson, J. E., & Mansfield, A. O. (2018). All pulmonary arteriovenous malformations are not the same: Radiological and clinical considerations. European Radiology, 28(8), 3450-3460. https://doi.org/10.1007/s00330-018-5308-2
12. Meyer, B. C., & Frericks, B. W. (2019). Cone-beam CT in interventional radiology: Technical principles and clinical applications. European Radiology, 29(11), 5981-5992. https://doi.org/10.1007/s00330-019-06189-4
13. Jayaraman, M. V., & Marcellus, M. L. (2020). Radiation safety in neurointerventional procedures. Neuroimaging Clinics of North America, 30(4), 701-710. https://doi.org/10.1016/j.nic.2020.08.003
14. Lee, B. B., Baumgartner, I., Berlien, H. P., Bianchini, G., Burrows, P., Gloviczki, P., & Loose, D. A. (2020). Diagnosis and treatment of venous malformations. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 8(2), 315-325. https://doi.org/10.1016/j.jvsv.2019.09.013
15. Maizels, M. S., & Kaufman, J. A. (2021). Embolization agents in interventional radiology: A comprehensive review. Radiographics, 41(2), 478-495. https://doi.org/10.1148/rg.2021200098
16. Nosko, M. G., & Dujovny, M. (2019). Arteriovenous malformation embolization with NBCA: Technical considerations. Interventional Neuroradiology, 25(3), 245-253. https://doi.org/10.1177/1591019918821357
17. Rosen, R. J., & Nassiri, N. (2019). Interventional treatment of arteriovenous malformations. Techniques in Vascular and Interventional Radiology, 22(4), 100646. https://doi.org/10.1016/j.tvir.2019.100646
18. Do, Y. S., Park, K. B., & Park, H. S. (2021). Extremity arteriovenous malformations involving the bone: Treatment with transcatheter embolization. Journal of Vascular and Interventional Radiology, 32(1), 78-86. https://doi.org/10.1016/j.jvir.2020.09.023
19. Linden, A. F., & Guzman, R. (2019). Arteriovenous malformations: Pathogenesis, genetics, and clinical management. Stroke, 50(12), 3544-3552. https://doi.org/10.1161/STROKEAHA.119.026038
20. Choudhri, O. A., & Feroze, A. H. (2020). Endovascular management of spinal vascular malformations. Neurosurgery Clinics, 31(1), 129-140. https://doi.org/10.1016/j.nec.2019.08.011
21. Miller, D. L., Balter, S., Schueler, B. A., Glass, C., Strauss, K. J., & Vano, E. (2020). Clinical radiation management for fluoroscopically guided interventional procedures. Journal of Vascular and Interventional Radiology, 31(8), 1338-1342. https://doi.org/10.1016/j.jvir.2020.04.020
22. Vano, E., Fernandez, J. M., & Ten, J. I. (2019). Occupational radiation doses in interventional cardiology: A 15-year follow-up. Journal of Vascular and Interventional Radiology, 30(12), 1963-1970. https://doi.org/10.1016/j.jvir.2019.07.006
23. Walcott, B. P., & Nahed, B. V. (2019). Radiation exposure in interventional neuroradiology: Staff dosimetry and risk reduction strategies. Journal of NeuroInterventional Surgery, 11(8), 789-794. https://doi.org/10.1136/neurintsurg-2018-014423
24. Bhatia, K. K., & Handa, A. (2020). Radiation protection strategies in the interventional radiology suite. Clinical Radiology, 75(9), 665-672. https://doi.org/10.1016/j.crad.2020.04.012
25. Salmela, M. B., & McClure, T. (2021). Quality improvement in interventional radiology: Reducing radiation dose and contrast volume. Journal of the American College of Radiology, 18(5), 712-720. https://doi.org/10.1016/j.jacr.2020.12.014
26. Krings, T., Geibprasert, S., & Terbrugge, K. G. (2019). Classification and endovascular management of pediatric cerebral vascular malformations. Neurosurgical Clinics, 21(3), 463-482. https://doi.org/10.1016/j.nec.2019.03.008
27. SATMED Health. (2026). SATMix: Single-use mixing kit for interventional embolization. https://www.satmed-health.com/satmix/
28. SATMED Health. (2026). SATPro: Disposable sterile radiation protection drape technical specifications. https://www.satmed-health.com/satpro/
29. SATMED Health. (2026). SATLine: Interventional access and delivery systems. https://www.satmed-health.com/satline/
30. SATMED Health. (2026). SATSurgical: Precision surgical and interventional consumables. https://www.satmed-health.com/satsurgical/
31. SATMED Health. (2026). SATJect: Advanced injection systems for interventional radiology. https://www.satmed-health.com/satject/
32. SATMED Health. (2026). SATSyringe: Specialized syringe systems for embolization procedures. https://www.satmed-health.com/satsyringe/
33. SATMED Health. (2026). SATDrape: Advanced sterile draping solutions for interventional suites. https://www.satmed-health.com/satdrape/
34. SATMED Health. (2026). SATCare CT and MRI Contrast Calculator: Clinical decision support. https://www.satmed-health.com/contrast-media-calculator/
35. SATMED Health. (2026). SATMix Calculator: Evidence-based emulsion preparation guidance. https://www.satmed-health.com/satmix-calculator/
36. SATMED Health. (2026). Extravasation Risk Calculator: Patient safety decision tool. https://www.satmed-health.com/extravasation-risk-calculator/
37. SATMED Health. (2026). SATLine Consumable Calculator: Inventory and cost management. https://www.satmed-health.com/satline-calculator/
38. SATMED Health. (2026). Integrated quality assurance platform for interventional radiology. https://www.satmed-health.com/register/
39. SATMED Health. (2026). Real-time analytics and protocol standardization for IR departments. https://www.satmed-health.com/register/
40. SATMED Health. (2026). Comprehensive interventional radiology training and certification programs. https://www.satmed-health.com/register/
41. SATMED Health. (2026). Advanced embolization technique workshops and simulation training. https://www.satmed-health.com/register/
42. SATMED Health. (2026). Peer-reviewed clinical protocols and evidence-based practice guidelines. https://www.satmed-health.com/register/